Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Industry News Regenerative Medicine

Regenerative Remake

2 years, 11 months ago

1165  0
Posted on Oct 14, 2015, 6 a.m.

The company best known for its green photo-film boxes, Fujifilm forays into anti-aging  lotions and stem cell R&D.

With Chairman Shigetaka Komori at its helm, Fujifilm Holdings Corp. shifts the company away from photo-film and to new science and technology markets: Ebola drugs, anti-aging lotions and stem cell research. Over the last decade, Komori diversified into new businesses as demand for the company’s trademark green photo- film boxes plummeted and archrival Eastman Kodak Co. went bankrupt. Fujifilm this year reported record profit of 119 billion yen ($950 million) and analysts expect a jump of more than 5 percent by next spring. Last month it announced a 100 billion yen share buyback -- its largest ever.  Now, Fujifilm is venturing further into unchartered territory, with plans to spend more than 400 billion yen on acquisitions by 2017, add new product lines and make a more aggressive push into health care. Among the new ideas: a filter for natural gas purification and stem cells capable of regenerating tissue in the human body.

Subscribe to our Newsletter

WorldHealth Videos

WorldHealth Sponsors